Resources & Guides
Educational content about GLP-1 medications, pharmacokinetics, and optimizing your treatment journey.
GLP-1 Medication Hubs
Comprehensive guides for each GLP-1 medication—dosing protocols, clinical trial data, microdosing strategies, and our free calculators.
Semaglutide Guide
Ozempic & Wegovy: GLP-1 receptor agonist. ~15% weight loss, 7-day half-life. FDA-approved for diabetes and weight management.
Tirzepatide Guide
Mounjaro & Zepbound: Dual GLP-1/GIP agonist. ~21% weight loss, 5-day half-life. The first dual-agonist approved by FDA.
Retatrutide Guide
Triple GLP-1/GIP/Glucagon agonist. ~24% weight loss in trials, 6-day half-life. Expected FDA approval 2027.
Educational Content
Retatrutide (GLP-3) Dosing Guide: 2mg to 12mg Protocol
guidesComplete GLP-3 retatrutide dosage guide covering the 2mg to 12mg weekly titration protocol, printable dosing chart, half-life pharmacokinetics, weight loss results from clinical trials, side effects management, and a free interactive dosing calculator.
Retatrutide Dosing Schedule: Week-by-Week Protocol (1mg to 12mg)
guideComprehensive guide to understanding retatrutide dosing schedules, titration protocols, and dosage optimization for effective weight loss results.
Complete Tirzepatide Dosing Guide (2026)
guidesEverything you need to know about tirzepatide dosing: dual-agonist mechanism, clinical trial efficacy data, starting dose through maintenance, titration schedules, half-life pharmacokinetics, side effects, and dosing calculator.
Complete Semaglutide Dosing Guide (2026)
guidesEverything you need to know about semaglutide dosing: GLP-1 mechanism, clinical trial efficacy data, starting dose through maintenance, titration schedules, half-life pharmacokinetics, side effects, and how to use a dosing calculator.